Jeff Yass’s Immix Biopharma IMMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$660K Buy
63,400
+41,400
+188% +$469K ﹤0.01% 9008
2026
Q2
$227K Sell
22,000
-69,400
-76% -$644K ﹤0.01% 11679
2026
Q1
$833K Buy
91,400
+38,400
+72% +$282K ﹤0.01% 8377
2025
Q4
$277K Buy
+53,000
New +$218K ﹤0.01% 10133

Other funds holding IMMX

Jeff Yass's IMMX Position: Q3 2026 in Review

Jeff Yass increased its Immix Biopharma (IMMX) stake by 71% in Q3 2026, buying an estimated $309K and bringing the position to 66,058 shares worth $687K. The position accounts for ﹤0.01% of the portfolio, ranked #8908.

Jeff Yass first reported a position in IMMX in Q1 2023 and has held it in 10 quarters since. The position peaked at $4.29M in Q1 2026. 136 funds tracked by Wall St. Rank hold IMMX as of Q3 2026.

  • Jeff Yass held 66,058 shares of Immix Biopharma worth $687K as of Q3 2026.
  • Jeff Yass bought 27,327 Immix Biopharma shares in Q3 2026, an estimated $309K.
  • Immix Biopharma made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #8908 holding.
  • Jeff Yass first reported a position in Immix Biopharma in Q1 2023 and has held it in 10 quarters since.
  • Jeff Yass's Immix Biopharma position peaked at $4.29M in Q1 2026.
  • 136 funds tracked by Wall St. Rank held Immix Biopharma as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.